177 related articles for article (PubMed ID: 3132393)
1. Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspectives for the future.
Young LS
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):93-7. PubMed ID: 3132393
[TBL] [Abstract][Full Text] [Related]
2. Use of fluoroquinolones as prophylactic agents in patients with neutropenia.
Patrick CC
Pediatr Infect Dis J; 1997 Jan; 16(1):135-9; discussion 160-2. PubMed ID: 9002124
[TBL] [Abstract][Full Text] [Related]
3. Chemoprophylaxis of gram-negative infections in neutropenic patients.
Klastersky J
Eur Urol; 1990; 17 Suppl 1():40-5. PubMed ID: 2162299
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
Zinner SH
Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
[TBL] [Abstract][Full Text] [Related]
5. A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients.
Klastersky J
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):201S-207S. PubMed ID: 2686921
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
Candoni A; Russo D; Salmaso F
Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of quinolones in the prevention of gram-negative bacteremia in neutropenic cancer patients and in the treatment of enteric infections.
Bow EJ; Louie TJ
Clin Invest Med; 1989 Feb; 12(1):61-8. PubMed ID: 2646056
[TBL] [Abstract][Full Text] [Related]
8. Emergence of resistance as a consequence of antimicrobial prophylaxis in immunocompromised patients.
Dejace P; Klastersky J
Scand J Infect Dis Suppl; 1986; 49():165-71. PubMed ID: 3547622
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C
J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702
[TBL] [Abstract][Full Text] [Related]
10. Prevention of infections in neutropenic patients with pefloxacin.
Meunier F
J Antimicrob Chemother; 1990 Oct; 26 Suppl B():69-73. PubMed ID: 2258354
[TBL] [Abstract][Full Text] [Related]
11. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
Rolston KV; Bodey GP; Elting L
Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
[TBL] [Abstract][Full Text] [Related]
12. The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.
Del Favero A; Menichetti F
Eur J Cancer; 1993; 29A Suppl 1():S2-6. PubMed ID: 8427721
[TBL] [Abstract][Full Text] [Related]
13. Protecting neutropenic patients from bowel-derived organisms.
Warren RE
J Hosp Infect; 1991 Sep; 19 Suppl C():43-58. PubMed ID: 1684195
[TBL] [Abstract][Full Text] [Related]
14. Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation.
Clasener HA; Vollaard EJ; van Saene HK
Rev Infect Dis; 1987; 9(2):295-328. PubMed ID: 3296099
[TBL] [Abstract][Full Text] [Related]
15. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.
Cruciani M; Concia E; Navarra A; Perversi L; Bonetti F; Aricò M; Nespoli L
Infection; 1989; 17(2):65-9. PubMed ID: 2654019
[TBL] [Abstract][Full Text] [Related]
17. From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
Hughes WT; Armstrong D; Bodey GP; Feld R; Mandell GL; Meyers JD; Pizzo PA; Schimpff SC; Shenep JL; Wade JC
J Infect Dis; 1990 Mar; 161(3):381-96. PubMed ID: 2179420
[No Abstract] [Full Text] [Related]
18. Antimicrobial prophylaxis against infection in neutropenic patients.
Young LS
J Infect Dis; 1983 Apr; 147(4):611-4. PubMed ID: 6842001
[No Abstract] [Full Text] [Related]
19. Single-agent therapy for infections in neutropenic cancer patients.
Fainstein V; Bodey GP
Am J Med; 1985 Aug; 79(2A):83-8. PubMed ID: 3895923
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial prophylaxis for infection in neutropenic patients.
Bodey GP
Curr Clin Top Infect Dis; 1988; 9():1-43. PubMed ID: 3077285
[No Abstract] [Full Text] [Related]
[Next] [New Search]
